Stock screenerAll disclosures → EDGAR →
HBIO
Conviction 61IndustrialsScan · Thu, Jun 25, 2026HBIO$6.00-1.32%
ResistanceSupportVol 14Vol MA14 19.42K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price6.00
Change-1.32%
Gap-1.32%
Rel volume0.24×
Avg volume23.59K
Avg $ vol145.99K
SMA 206.14
SMA 506.14
SMA 2002.44
Price vs 50-2.32%
Price vs 200+146.37%
MA stackmixed
50/200 cross—
Supertrendup · 5.12
RSI (14)50
MACD hist-0.03
MACD crossbear · 7d
Stoch %K / %D25 / 29
ADX (14)17
+DI / −DI22 / 16
RSI divergence—
MACD divergenceBearish
ATR %+6.29%
ADR %6.24%
52w high7.24
52w low0.3793
From 52w high-17.13%
Above 52w low+1481.86%
New 52w highNo
SqueezeOn · 5d
Bollinger width14.60%
%B0.34
Donchian pos29.59%
Donchian high6.69
Donchian low5.71
AVWAP (52w high)6.10
vs AVWAP high-1.69%
AVWAP (52w low)0.7094
vs AVWAP low+745.79%
OBV trendUp
Chaikin MF (20)0.12
Today vs 20d0.24×
Avg vol (14d)19.42K
Avg vol (20d)23.59K
Avg $ vol (20d)145.99K
Market cap27.06M
RS 3m (vs SPY)+6.26%
RS 6m (vs SPY)+699.17%
RS line new highNo
Trend template7/8
Technical rank80.3
1 week+0.00%
1 month+5.63%
3 months+16.96%
6 months+695.44%
1 year+1032.72%
YTD+820.39%
P/E-0.48
P/B2.69
P/S0.31
P/FCF4.95
EPS-1.28
Div yield—
ROE-564.40%
ROA-72.75%
Debt/Eq3.60
Current1.99
EV/EBITDA-1.27
Gross margin57.67%
Net margin-65.51%
Rev growth-8.06%
EPS growth-357.07%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value56.17M
Revenue20.75M
Net income-3.42M
Gross profit12.24M
Free cash flow5.47M
IndustryLABORATORY ANALYTICAL INSTRUMENTS
ExchangeNasdaq
Shares out4.51M
Employees339
ListedThu, Dec 7, 2000
Free float3.35M
Float %74.3%
Short interest106.2K
Days to cover3.8d
Short volume39.6%
Squeeze score25 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeB
Conviction61 / 100
Pattern quality—
Tech rank80.3 / 100
Group rank77 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance7.10
Support5.32
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in HBIO
No recent disclosed trades by Congress in HBIO. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in HBIO
No recent insider (Form 4) filings in HBIO. Insiders must file within two business days of a trade.
SEC filings
EDGAR filings in HBIO · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.